Evidence map›Paper›PMID 30062477›Full record

ArticleJournal of the American Society for Mass Spectrometry2019

Native Top-Down Mass Spectrometry and Ion Mobility Spectrometry of the Interaction of Tau Protein with a Molecular Tweezer Assembly Modulator.

Michael Nshanian, Carter Lantz, Piriya Wongkongkathep, Thomas Schrader, Frank-Gerrit Klärner, Anika Blümke, Clément Despres, Michael Ehrmann, Caroline Smet-Nocca, Gal Bitan and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A Conformation-Specific Approach to Native Top-down Mass Spectrometry.Journal of the American Society for Mass Spectrometry · 2024
    Article
  5. Article
  6. Article
  7. Water Plays Key Roles in Stabilities of Wild Type and Mutant Transthyretin Complexes.Journal of the American Society for Mass Spectrometry · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Top-down proteomics.Nature reviews. Methods primers · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Dissecting the structural heterogeneity of proteins by native mass spectrometry.Protein science : a publication of the Protein Society · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Three-repeat and four-repeat tau isoforms form different oligomers.Protein science : a publication of the Protein Society · 2022
    Article
  20. Novel Strategies to Address the Challenges in Top-Down Proteomics.Journal of the American Society for Mass Spectrometry · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Michael NshanianDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Carter LantzDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Piriya WongkongkathepDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Thomas SchraderInstitute of Chemistry, University of Duisburg-Essen, Essen, Germany.
Frank-Gerrit KlärnerInstitute of Chemistry, University of Duisburg-Essen, Essen, Germany.
Anika BlümkeCenter of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Universitaetsstrasse, Essen, Germany.
Clément DespresUMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Université Lille, CNRS, 59000, Lille, France.
Michael EhrmannCenter of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Universitaetsstrasse, Essen, Germany.
Caroline Smet-NoccaUMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Université Lille, CNRS, 59000, Lille, France.
Gal BitanDepartment of Neurology and Brain Research Institute, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Joseph A LooDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, CA, 90095, USA. JLoo@chem.ucla.edu.ORCID http://orcid.org/0000-0001-9989-1437
University of California, Los Angeles · USUniversity of Duisburg-Essen · DECentre National de la Recherche Scientifique · FRUnité de Glycobiologie Structurale et Fonctionnelle · FR

Funding

UV Laser for Photodissociation-Mass Spectrometry of Proteins and Protein ComplexesR01GM103479 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, JOSEPH A · 2012 to 2021
$3.2M
Ultra-High Resolution Mass Spectrometer for Biomedical ResearchS10RR028893 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, JOSEPH A · 2010 to 2010
$2.7M
Investigation of the Effect of Structural Modifications of Tau on Assembly State and SeedingRF1AG054000 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BITAN, GAL · 2017 to 2021
$2.1M
Misfolded protein-clearance enhancers for Alzheimer's therapyR01AG050721 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BITAN, GAL · 2015 to 2019
$2.0M
High-Resolution Ion Mobility Mass SpectrometerS10OD018504 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, JOSEPH A · 2014 to 2014
$915k
National Institute of General Medical Sciences R01GM103479National Institute on Aging R01AG050721National Institute on Aging RF1AG054000National Institutes of Health S10OD018504National Institutes of Health S10RR028893NCRR NIH HHS S10 RR028893NIA NIH HHS R01 AG050721NIA NIH HHS RF1 AG054000NIGMS NIH HHS R01 GM103479NIH HHS S10 OD018504
6 · The paper itself

Abstract

Native top-down mass spectrometry (MS) and ion mobility spectrometry (IMS) were applied to characterize the interaction of a molecular tweezer assembly modulator, CLR01, with tau, a protein believed to be involved in a number of neurodegenerative disorders, including Alzheimer's disease. The tweezer CLR01 has been shown to inhibit aggregation of amyloidogenic polypeptides without toxic side effects. ESI-MS spectra for different forms of tau protein (full-length, fragments, phosphorylated, etc.) in the presence of CLR01 indicate a primary binding stoichiometry of 1:1. The relatively high charging of the protein measured from non-denaturing solutions is typical of intrinsically disordered proteins, such as tau. Top-down mass spectrometry using electron capture dissociation (ECD) is a tool used to determine not only the sites of post-translational modifications but also the binding site(s) of non-covalent interacting ligands to biomolecules. The intact protein and the protein-modulator complex were subjected to ECD-MS to obtain sequence information, map phosphorylation sites, and pinpoint the sites of inhibitor binding. The ESI-MS study of intact tau proteins indicates that top-down MS is amenable to the study of various tau isoforms and their post-translational modifications (PTMs). The ECD-MS data point to a CLR01 binding site in the microtubule-binding region of tau, spanning residues K294-K331, which includes a six-residue nucleating segment PHF6 (VQIVYK) implicated in aggregation. Furthermore, ion mobility experiments on the tau fragment in the presence of CLR01 and phosphorylated tau reveal a shift towards a more compact structure. The mass spectrometry study suggests a picture for the molecular mechanism of the modulation of protein-protein interactions in tau by CLR01. Graphical Abstract ᅟ.

Indexed as

Binding SitesBridged-Ring CompoundsHydrogen-Ion ConcentrationIon Mobility SpectrometryOrganophosphatesPhosphorylationSpectrometry, Mass, Electrospray Ionizationtau ProteinsBridged-Ring CompoundsCLR01 compoundOrganophosphatestau ProteinsElectron capture dissociationElectrospray ionizationNative mass spectrometryTauTop-down mass spectrometryTweezer

Identifiers

PMID30062477
PMCPMC6320309
OpenAlexW2885822106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.